RenBio, Inc.
- Biotech or pharma, therapeutic R&D
- Medical device or technology
RenBio focuses on delivery of DNA therapeutics using its novel MYO Technology™ to enable sustained production of a range of antibodies and proteins targeting infectious diseases, inflammatory diseases, blood disorders, and metabolic disease. In addition to its internal development programs, RenBio also seeks to partner its proprietary technology.